Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination
Study Details
Study Description
Brief Summary
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection.
The research is focused on these questions:
Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Community Group Survey Community members coming into the University Health Shreveport Ambulatory Care Facility. |
Other: Survey
Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination
|
Physician Group Survey Physicians affiliated with LSU Health Shreveport School of Medicine |
Other: Survey
Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination
|
Outcome Measures
Primary Outcome Measures
- Barriers to HPV Vaccination [60 days]
What are the barriers which prevent community members and physicians, residents and medical students from ensuring that males age 9-26 are vaccinated with the HPV three-shot vaccination.
Secondary Outcome Measures
- Knowledge pertaining to ease of Human Papillomavirus transmission. [60 days]
Do community members and physicians understand the ease of HPV transmission?
- Knowledge of Associated HPV diseases [60 days]
Do community member and physicians know the associated HPV diseases?
- Knowledge of age in which males should be vaccinated against HPV. [60 days]
Do community member and physicians know the age in which males should be vaccinated against HPV?
Eligibility Criteria
Criteria
Community Participants
Inclusion
All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics willing to complete a survey
Community Study Exclusion
Those do not wish to participate in the study
Those who English is not their first language
Clinical Faculty, Resident, and Medical Student Study
Inclusion
All Louisiana State University Shreveport Health Clinical Faculty, Resident, and Medical Student Inclusion willing to to complete the online survey.
Clinical Faculty, Resident, and Medical Student Study
Exclusion
Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines to take the survey or do not attempt to complete it.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Louisiana State University Health | Shreveport | Louisiana | United States | 71103 |
Sponsors and Collaborators
- Louisiana State University Health Sciences Center Shreveport
Investigators
- Principal Investigator: Julia M Esparza, MLS, 3186754179
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- STUDY00000618